Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH

WAYNE, Pa., May 07, 2024 -- Teleflex Incorporated , a global leader in medical technologies, today announced the presentation of new research findings from the 2024 American Urological Association...

Related Keywords

San Antonio ,Texas ,United States ,American ,Claus Roehrborn ,Jacqueline Welch ,Lawrence Keusch ,European Association Of Urology ,American Urological Association ,Ut Southwestern Medical Center ,Strategy Development ,Partner National Media Relations Specialist ,Exchange Commission ,Teleflex Incorporated ,American Urological Association Annual Meeting ,Urological Association Annual Meeting ,Prostatic Urethral Lift ,Vice President ,Global Clinical ,Scientific Operations ,User Facility Device Experience ,Medical Center ,Advanced Tissue Control ,Urological Association ,Minimally Invasive Surgery ,Initial Treatment ,Early Patient Experience Following Treatment With ,Two Contemporary ,Preliminary Results From ,Prostate Cancer Prostatic Dis ,Procedural Context ,Device Safety ,Intj Clin Pract ,Canj Urol ,Prostate Cancer ,Prostatic Dis ,Teleflex Interventional ,Annual Report ,Investor Relations ,Markets ,